Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - zuclopenthixol acetate, quantity: 100 mg (equivalent: zuclopenthixol, qty 90.5 mg) - injection, solution - excipient ingredients: fractionated coconut oil - initial treatment of acute psychoses, mania and exacerbation of chronic psychoses.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - zuclopenthixol acetate, quantity: 50 mg (equivalent: zuclopenthixol, qty 45.25 mg) - injection, solution - excipient ingredients: fractionated coconut oil - initial treatment of acute psychoses, mania and exacerbation of chronic psychoses.

Izrael - angličtina - Ministry of Health

lundbeck israel ltd. - zuclopenthixol acetate - solution for injection - zuclopenthixol acetate 50 mg/ml - zuclopenthixol - zuclopenthixol - acute psychoses.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - zuclopenthixol acetate; zuclopenthixol decanoate; zuclopenthixol hydrochloride -

Malta - angličtina - Medicines Authority

lundbeck limited 2nd floor, building 3 abbey view, everard close, st albans ali 2ps, united kingdom - zuclopenthixol acetate - solution for injection - zuclopenthixol acetate 50 mg/ml - psycholeptics

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - zuclopenthixol acetate 50 mg/ml - solution for injection - 50 mg/ml - active: zuclopenthixol acetate 50 mg/ml - initial treatment of acute psychoses, mania and exacerbation of chronic psychoses.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - zuclopenthixol decanoate, quantity: 200 mg - injection, solution - excipient ingredients: fractionated coconut oil - maintenance treatment of acute psychoses, mania and exacerbation of chronic psychoses. may be an advantage in the treatment of noncompliant patients.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - zuclopenthixol hydrochloride, quantity: 11.8 mg (equivalent: zuclopenthixol, qty 10 mg) - tablet, film coated - excipient ingredients: copovidone; purified talc; microcrystalline cellulose; lactose monohydrate; glycerol; potato starch; magnesium stearate; hydrogenated castor oil; titanium dioxide; hypromellose; macrogol 6000; iron oxide red - safety related notification and ammended text of the product information approved as described in the letter dated 28 may 2008 from ceu1. (sub#2008-1319-1) clopixol tablets: acute and chronic schizophrenia and other psychoses, especially those with symptoms such as hallucinations, delusions, thought disturbances, agitation, restlessness, hostility or aggressiveness. manic phase of manic depressive illness.

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

lundbeck ltd - zuclopenthixol acetate - solution for injection - 50mg/1ml

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

lundbeck ltd - zuclopenthixol acetate - solution for injection - 50mg/1ml